Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

30.43 +0.38 (+1.26%)
Streaming Delayed Price Updated: 3:24 PM EDT, Mar 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,038,580
Open 30.05
Bid (Size) 30.40 (200)
Ask (Size) 30.46 (600)
Prev. Close 30.05
Today's Range 29.78 - 31.04
52wk Range 29.43 - 90.32
Shares Outstanding 8,168,788
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors With Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit Retirement

Performance

YTD
-35.5%
-35.5%
1 Month
-22.1%
-22.1%
3 Month
-36.0%
-36.0%
6 Month
-55.4%
-55.4%
1 Year
-57.4%
-57.4%

More News

Read More
News headline image
SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors With Losses to Contact the Firm
Via TheNewswire.com
Topics Fraud Lawsuit Retirement
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Fraud Lawsuit Retirement
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via TheNewswire.com
Topics Fraud Lawsuit Retirement
News headline image
SLNO DEADLINE FOR LEADERSHIP is May 5, 2026 in a Securities Fraud Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) - Contact Kaplan Fox
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
SLNO DEADLINE FOR LEADERSHIP is May 5, 2026 in a Securities Fraud Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Kaplan Fox Reminds Investors of Soleno Therapeutics, Inc. (SLNO) to a Class Action Deadline on May 5, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
Kaplan Fox Reminds Investors of Soleno Therapeutics, Inc. (SLNO) to a Class Action Deadline on May 5, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Deadline Approaching for Investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO) - Contact Kaplan Fox Before May 5, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Deadline Approaching for Investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO) - Contact Kaplan Fox Before May 5, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Soleno Therapeutics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit Retirement
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit Retirement
News headline image
SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
SOLENO THERAPEUTICS Deadline to Lead in Securities Class Action Lawsuit is May 5, 2026 - Contact Kaplan Fox
Via TheNewswire.com
Topics Lawsuit
News headline image
SOLENO THERAPEUTICS Deadline to Lead in Securities Class Action Lawsuit is May 5, 2026 - Contact Kaplan Fox
Via NewMediaWire
Topics Lawsuit
News headline image
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO) Seeking Recovery - Contact Kaplan Fox Before Deadline on May 5, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO) Seeking Recovery - Contact Kaplan Fox Before Deadline on May 5, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SLNO
From Pomerantz LLP
Via GlobeNewswire
News headline image
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Commercial Viability Risks: Levi & Korsinsky
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire

Frequently Asked Questions

Is Soleno Therapeutics, Inc. - Common Stock publicly traded?
Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?
Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?
The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market
What is the current price of Soleno Therapeutics, Inc. - Common Stock?
The current price of Soleno Therapeutics, Inc. - Common Stock is 30.43
When was Soleno Therapeutics, Inc. - Common Stock last traded?
The last trade of Soleno Therapeutics, Inc. - Common Stock was at 03/30/26 03:24 PM ET
What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?
The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 248.58M
How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?
Soleno Therapeutics, Inc. - Common Stock has 249M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.